Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Sildenafil Citrate in Waldenstrom's Macroglobulinemia
This study has been terminated.
( Terminated for expired continuing review )
Study NCT00165295 Information provided by Dana-Farber Cancer Institute
First Received: September 9, 2005 Last Updated: December 19, 2007
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Waldenstrom's Macroglobulinemia
Additional conditions recognized in this trial
Waldenstrom Macroglobulinemia
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Lymphoproliferative Disorders
Neoplasms
Neoplasms by Histologic Type
Neoplasms, Plasma Cell
Paraproteinemias
Vascular Diseases
Interventions listed in this trial
Sildenafil citrate (Viagra)
Additional drug interventions recognized in this trial
Citric Acid
Sildenafil
More general drug interventions related to this trial
Anticoagulants
Cardiovascular Agents
Chelating Agents
Enzyme Inhibitors
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Phosphodiesterase Inhibitors
Therapeutic Uses
Vasodilator Agents
Sponsors listed in this trial
Dana-Farber Cancer Institute
Beth Israel Deaconess Medical Center
Back to top of Main Content
